Goldman Sachs, Bank of America, and Johnson & Johnson post first-quarter earnings that beat estimates. Read More...
AP Finance
J&J sales in US rise 10%, health care giant raises dividend
Johnson & Johnson beat first-quarter expectations, as growth in cancer treatments and the health care giant’s home market helped counter another revenue hit from the strong dollar. The health care giant booked a $68 million loss on a one-time charge in the quarter related to its baby powder, and revenue grew more than 5% to $24.75 billion, which was better than anticipated. Sales in pharmaceuticals, the company’s largest business, grew 4% in the quarter.
Add Comment